Log in to save to my catalogue

Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-h...

Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-h...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_855e78e2e14745259e95ef61051904bc

Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19

About this item

Full title

Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2023-01, Vol.14 (1), p.333-333, Article 333

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_855e78e2e14745259e95ef61051904bc

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_855e78e2e14745259e95ef61051904bc

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-023-35835-3

How to access this item